Q&A with Senator Adam Schiff on recursive AI becoming a real national security threat, making AI companies retain training data, needing an FDA for AI, and more
Today, I'm talking with Senator Adam Schiff, a Democrat from California. Sen. Schiff sits on a number of committees …
Meta adds an FDA-cleared hearing enhancement feature to supported Meta Glasses for Meta One subscribers or a one-time cost of $149, rolling out later in 2026
Why Meta is bringing hearing enhancement to its smart glasses
Doctors and researchers worry that FDA-related wagers on Kalshi and Polymarket could compromise drug development studies and erode public trust in the process
On the betting websites Kalshi and Polymarket, people can now wager on whether the Food and Drug Administration will decide this year …
An interview with Sriram Krishnan, who says “there will not be an FDA for AI” under Trump, blames the AI backlash on the industry's “doomer” messaging, and more
Sriram Krishnan tells the FT the president is against a centralised regulator as AI backlash grows
An interview with Sriram Krishnan, who says “there will not be an FDA for AI” under Trump, blames the AI backlash on the industry's “doomer” messaging, and more
Sriram Krishnan tells the FT the president is against a centralised regulator as AI backlash grows
Inside the Trump admin's push to integrate AI into the healthcare system, including an FDA regulatory fast track for digital health tech like AI chatbots
The administration is laying the groundwork for chatbots that can diagnose illness and prescribe medicine, but physicians say AI can introduce more problems.
Inside the Trump admin's push to integrate AI into the healthcare system, including an FDA regulatory fast track for digital health tech like AI chatbots
The administration is laying the groundwork for chatbots that can diagnose illness and prescribe medicine, but physicians say AI can introduce more problems.
Mental health startup Kintsugi is shutting down and open-sourcing its AI tech to detect depression and anxiety, after failing to secure FDA clearance
Instead, a mental health startup shut down and open-sourced its tech. … For the past seven years, the California-based startup Kintsugi …
Paradromics says it received FDA approval for a human trial of its Connexus brain implant, aimed at restoring speech to those with severe motor impairments
The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.